glp 1 documentary GLP-1 Drug Overdoses Are on the Rise: What You Need to Know The GLP-1 Memoirs | Podcast
Description
Its estimated that nearly fifty percent of the US population deals with some form of chronic illness
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
It worked until it didnt
Ingredients: Proprietary Blend
What this means for food R&D.
The GLP-1 market is led by semaglutide products Ozempic and Wegovy (Novo Nordisk) and tirzepatide products Mounjaro and Zepbound (Lilly)
